Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meloxicam Injection Efficacy in Abdominoplasty
NCT05950152Phase 2Unknown
- Sponsor
- Beijing Tide Pharmaceutical Co., Ltd.
- Start
- Jul 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of meloxicam in postoperative pain, sponsored by Beijing Tide Pharmaceutical Co., Ltd.. Status: unknown.
02
Drugs
meloxicam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05950152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05950152.